To Treat or Not to Treat: Assessing Risk and Treatment Options in High-Risk SMM

The care of patients diagnosed with smoldering multiple myeloma (SMM) continues to evolve with the rapid release of new clinical evidence. Listen to this podcast with 2 experts discussing what healthcare professionals need to know about risk stratification, how to interpret evidence for early intervention, and how to decide between treatment and observation in an individualized manner. They will also discuss optimal treatment selection and sequencing considerations, proactive and mitigation approaches to ensure treatment safety, supportive care measures, optimization of shared decision-making and patient communication, and emerging therapies and key ongoing clinical trials for patients with high-risk SMM.